![Linda Burkly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Linda Burkly
Chief Tech/Sci/R&D Officer at
EDITAS MEDICINE, INC.
Net worth: 202 076 $ as of 30/06/2026
Profile
Linda C.
Burkly is Chief Scientific Officer & Executive VP at Editas Medicine, Inc. since 2023.
Formerly, Dr. Burkly was Vice President & Senior Distinguished Investigator at Biogen, Inc. from 2014 to 2022.
Education includes an undergraduate degree from Fairfield University and a doctorate from Tufts University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 28/07/2026 | 62,369 ( 0.04% ) | 202 076 $ | 30/06/2026 |
Linda Burkly active positions
| Companies | Position | Start |
|---|---|---|
| EDITAS MEDICINE, INC. | Chief Tech/Sci/R&D Officer | 24/07/2023 |
Former positions of Linda Burkly
| Companies | Position | End |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2022 |
Training of Linda Burkly
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
78
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Fairfield University
 Fairfield University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
- Stock Market
- Insiders
- Linda Burkly
